InvestorsHub Logo
Followers 0
Posts 15
Boards Moderated 0
Alias Born 04/19/2013

Re: None

Friday, 12/06/2019 4:47:37 PM

Friday, December 06, 2019 4:47:37 PM

Post# of 426778
Thanks all for responses.. I had not considered royalties vs actual sales.

In regards to Canada population.. I guess at 3x US market penetration due to 1. universal access to care and
2. large proportion of population on extremely low deductible ($25 to $50)
per year drug plans.

I might add that some European markets have pharmacare perhaps adding to market penetration.

Clearly many variables in play looking at international sales... this is a great drug and I feel certain well all do well if we hold firm.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News